Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Fit in the head with ginkgo

Six-week study documents increase in memory performance

    • General Internal Medicine
    • News
    • Pharmaceutical medicine
    • RX
    • Studies
  • 3 minute read

The positive effect of Ginkgo biloba extract EGb 761® and similar Ginkgo preparations on cognitive disorders is sufficiently documented. But does ginkgo also work in younger, healthy individuals?

The first four clinical studies investigating the beneficial effects of EGb 761 extract® on memory and retentiveness were conducted with mentally intact seniors [1– 4]. Two of them showed a positive result [1,2], two others a negative [3,4]. However, the results of the negative studies must be questioned: The special circumstances of persons with intact brain performance were not taken into account in either study.

Does it also work for younger people?

Kaschel [5] took it to a new level when he investigated in 2011 whether EGb 761® can improve brain performance, i.e. memory and retentiveness, in healthy individuals who are not yet seniors. His subjects were between 45 and 65 years old, middle-aged. In his randomized, double-blind, placebo-controlled study, Kaschel examined 188 men and women between the ages of 45 and 65 with intellectual levels in the normal range. During six weeks, a total of 177 subjects underwent all tests (88 verum vs. 89 placebo). The per-protocol group consisted of 159 subjects (80 verum vs. 79 placebo). A dose of 240 mg EGb 761® (single dose or placebo) was administered daily. The outcome variables were defined by scores on everyday memory tests and subjective memory performance.

Positive results!

Table 1 shows significant superiority of EGb 761 extract® over placebo in 3 of 5 tests performed. The tests included qualitative and quantitative immediate and delayed (after 45 minutes) recall, as well as a test of how well subjects could recognize a path. In both quantitative recall tests, taking EGb 761 resulted in significant superiority over placebo (p=0.038 and 0.008, respectively). In qualitative recall, the verum group also performed significantly better in delayed recall and tended to perform better in immediate recall. With regard to route recognition, both groups performed equally well. However, the test arrangement allowed for an average result when randomly selected, which could imply some bias in the result. The subjects were also interviewed after the tests regarding their well-being and state of mind. There were no changes in general well-being or mood in either study group.

 

 

Interpretation

The results of this study by Kaschel allows several conclusions to be drawn:

  1. EGb 761® can be successfully used not only in elderly individuals with cognitive disorders, but also in middle-aged individuals with intact cognitive performance.
  2. EGb 761® leads to a significant increase in memory performance in this population.
  3. The benefits for increasing quantitative memory performance are particularly pronounced.
  4. The treatment and tests did not result in any changes in the mind and mood.

For everyday practice this means: The Ginkgo biloba extract EGb 761® can be used in everyday practice for people who are in a phase of life in which an improvement in memory performance is required.

 

Literature:

  1. Mix JA, Crews WD Jr: A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 671 in a sample of cognitively intact older adults: neuropsychological findings. Hum Psychopharmacol 2002; 17(6): 267-277.
  2. Mix JA, Crews WD Jr: An examination often the efficacy of the Ginkgo biloba extract EGb 671 on the neuropsychological functioning of cognitively intact older adults. J Altern Complement Med 2006; 6(3): 219-229.
  3. Snitz BE, et al: Ginkgo biloba for Preventing Cognitive Decline in Older Adults A Randomized Trial. JAMA 2009; 302(24): 2663-2670.
  4. Solomon PR, et al: Ginkgo for memory enhancement. A randomized controlled trial. JAMA 2002; 288(7): 835-840.
  5. Kaschel R: Specific memory effects on Ginkgo biloba extract EGb 671 in middle-aged healty volunteers. Phytomedicine 2011: 18(14): 1202-1207.

 

HAUSARZT PRAXIS 2019; 14(5): 6-8

Autoren
  • Dr. pharm. Christoph Bachmann
Publikation
  • HAUSARZT PRAXIS
Related Topics
  • Ginkgo
  • memory
Previous Article
  • Andrology

Men’s health: is there an andropause?

  • Education
  • Endocrinology and Diabetology
  • General Internal Medicine
  • RX
  • Studies
View Post
Next Article
  • Gastroesophageal reflux disease

Better symptom control and patient satisfaction with add-on therapy

  • Gastroenterology and Hepatology
  • General Internal Medicine
  • Market & Medicine
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 6 min
  • Treatment of vitiligo

Focus on patient perspective and disease activity

    • Congress Reports
    • Dermatology and venereology
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 5 min
  • Vaccine-preventable respiratory diseases

RSV and pneumococci: recommendations for risk groups

    • Congress Reports
    • General Internal Medicine
    • Infectiology
    • Pediatrics
    • Pneumology
    • Prevention and health care
    • RX
    • Studies
View Post
  • 5 min
  • Circadian rhythm in asthma

Chronotherapy can improve control

    • Allergology and clinical immunology
    • General Internal Medicine
    • Pneumology
    • RX
    • Studies
View Post
  • 6 min
  • Update on diagnostics, risk stratification and therapy

Acute myeloid leukemia 2025

    • Education
    • Hematology
    • Oncology
    • RX
    • Studies
View Post
  • 4 min
  • New practice guideline for fibromyalgia syndrome

Good times, bad times

    • Congress Reports
    • General Internal Medicine
    • Neurology
    • Pharmacology and toxicology
    • Physical medicine and rehabilitation
    • Rheumatology
    • RX
    • Sports Medicine
    • Studies
View Post
  • 5 min
  • Findings from the TRACK-FA study

Neuroimaging biomarkers in Friedreich’s ataxia

    • Genetics
    • Neurology
    • Pediatrics
    • RX
    • Studies
View Post
  • 12 min
  • Doing sport without fear or risk

Doing sport without fear or risk

    • CME continuing education
    • Endocrinology and Diabetology
    • Pediatrics
    • RX
    • Sports Medicine
View Post
  • 8 min
  • Chronic inducible urticaria

What has stayed the same, what has changed?

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • RX
    • Studies
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
Top CME content
  • 1
    Doing sport without fear or risk
  • 2
    UV protection and skin cancer screening – Update 2025
  • 3
    Rare malignancy from a dermatological perspective
  • 4
    Yellow nail and Swyer-James syndrome
  • 5
    Diagnostic indications

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.